Measures,Gaps, and Mitigation Strategies in Bangladesh’s COVID-19 Response

EcoHealth - The Coronavirus Disease 2019 (COVID-19) spread rapidly from China to most other countries around the world in early 2020 killing millions of people. To prevent virus spread, world...     

Current progress of China’s free ART program

INTRODUCTION At the end of 2003, there were an estimated 840,000 people in China infected with HIV, among whom 80,000 were in need of antiretroviral therapy (ART) [1]. Since 1999, the annual rate of increase in reported HIV infec- tions has been around 30%, with growing numbers of females becoming infected [1]. The transmission of HIV/ AIDS in China has been through intravenous drug use (43. 2%) in the south, southwest, and western provinces; prior commercial blood and plasma selli…     

Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?

Science China Life Sciences - The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people and caused tremendous morbidity and mortality worldwide....     

Saving Europe’s threatened flora: progress towards GSPC Target 8 in Europe

The European flora is of global significance but many species are facing an ever increasing range of threats, especially the growing impacts of climate change. While various estimates have been made for the number of threatened plant species in Europe, an up-to-date European plant Red List does not presently exist. Target 8 of the Global Strategy for Plant Conservation (GSPC) calls for 60% of threatened plant species to be conserved in ex situ collections by 2010. In the absence of a European plant Red List, it is difficult to monitor progress at the regional level towards this target. To address this gap Botanic Gardens Conservation International (BGCI) has developed a consolidated list of European threatened species as a step towards a formal Red List. The database consists of national Red List data from 28 European countries and includes records for over 11,000 taxa. National Red List data were supplemented by information on the critically endangered plants of Europe provided by the Museum National d’Histoire Naturelle/European Topic Centre on Biological Diversity and the Conservatoire Botanique National de Brest. A list of regionally threatened species was extracted from the database and screened against BGCI’s database of plants in cultivation in botanic gardens (PlantSearch) and ENSCONET’s (European Native Seed Conservation Network) database of plants conserved in European seed banks. This analysis revealed that 42% of European threatened species are currently included in ex situ conservation programmes in Europe.     

COVID-19: disease,or no disease? - that is the question. It’s the dose stupid!

The COVID-19 pandemic has raised many issues not the least of which is the reason for its high variability in consequences to the infected person. In this opinion letter, we advocate that the dose and presentation of the infecting virus is a major factor that affects whether the outcome is subclinical, tissue damaging or even lethal following infection. We briefly describe the known effects of virus dose on the course COVID-19 and discuss practical maneuvers as well as largely untested procedures that can raise the threshold dose needed to break through barriers of resistance.     

Coronavirus disease 2019 (COVID-19): internamiento involuntario sí, tratamiento obligatorio no

We had the opportunity to know a judicial decision in relation to a nonagenarian COVID-19 patient, which is clarifying regarding the complex issue of involuntary admission and involuntary treatment of the elderly. The judge authorized the involuntary admission but denied the possibility of imposing medical treatment against the will of the patient.This situation invites us to review the different types of involuntary admission that our legal system provides and how involuntary medical treatment is regulated according to its purpose and the patient's ability to decide.In the field of public health, the determining element to be able to impose any sanitary measure against the will of the patient is the risk to the health of the population. In the case presented, the judge rejects the possibility of authorizing medical treatment for not contributing anything from the point of view of public health. However, it does authorize involuntary admission as it is essential to guarantee isolation.     

COVID-19疫苗的研究进展

新型冠状病毒肺炎(Coronavirus disease 2019,COVID-19)是由新型冠状病毒(Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)引起的一种新的传染病。阻止COVID-19流行最有效的方法就是研制安全有效的疫苗,目前国内外多家机构开展了COVID-19疫苗的研究,包括核酸疫苗、病毒载体疫苗、灭活疫苗、重组蛋白疫苗、减毒流感病毒载体疫苗等不同类型,并取得了快速进展。本文对COVID-19疫苗的类型、研究进展、存在的问题等进行综述。     

Naming and Necessity: Sherborn’s Context in the 19th Century

By the late 19^th Century, storms plaguing early Victorian systematics and nomenclature seemed to have abated. Vociferous disputes over radical renaming, the world-shaking clash of all-encompassing procrustean systems, struggles over centres of authority, and the issues of language and meaning had now been settled by the institution of a stable imperial museum and its catalogues, a set of rules for the naming of zoological objects, and a new professional class of zoologists. Yet, for all that tranquillity, the disputes simmered below the surface, re-emerging as bitter struggles over synonyms, trinomials, the subspecies category, the looming issues of the philosophy of scientific language, and the aggressive new American style of field biology – all pressed in upon the received practice of naming and classifying organisms and the threat of anarchy. In the midst rose an index. This paper will explore the context of CD Sherborn’s Index Animalium and those looming problems and issues which a laborious and comprehensive “index of nature” was meant to solve.     

Immune response in COVID-19: what is next?

The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future. Subject terms: Infectious diseases, Antimicrobial responses     

Survivin’s Dual Role: An Export’s View

Survivin is proposed to function as a mitotic regulator and an apoptosis inhibitor duringdevelopment and pathogenesis. As such, survivin has aroused keen interest in disparateareas of basic and translational research. Survivin acts as a subunit of the chromosomalpassenger complex (CPC), composed of the mitotic kinase Aurora-B, Borealin 5 and INCENP,and is essential for proper chromosome segregation and cytokinesis. Our recent findingsindicate that the nuclear export receptor Crm1 is critically involved in tethering the CPC to thecentromere by interacting with a leucine-rich nuclear export signal (NES), evolutionaryconserved in all mammalian survivin proteins. In addition, the survivin/Crm1 interaction10 seems to be required for the cytoprotective activity of survivin, because export deficientsurvivin fails to protect tumor cells against cancer therapy-induced apoptosis. These findingsappear of clinical relevance since preferential nuclear localization of survivin turned out to bea favorable prognostic factor in cancer patients. Besides emphasizing the functionalsignificance of the Crm1/survivin interface, we suggest to exploit the pharmacogenetic15 interference with survivin’s export as a novel strategy to antagonize survivin’s activity.